from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1664/pks9

LFCtreatmentdescriptionclass of inhibitor

1.541

Amikacinug/mL Amikacintranslation

0.952

Cap5-10ug/mL Capreomycintranslation

1.759

Rox10-50 ug/mL Roxithromycintranslation

0.655

SM2-5 ug/mL Streptomycintranslation

2.851

Tet5-10 ug/mL Tetracyclinetranslation

0.322

Rif0.2-5ug/mL Rifampicintranscription

0.240

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.210

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.556

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.357

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.271

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.070

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.264

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.189

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.350

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.192

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.322

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.478

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.164

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.642

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.124

KCN5-20 ug/mL Potassium cyaniderespiration

0.180

NaN30.2-2 mM Sodium aziderespiration

0.806

Nigericin50 uM Nigericinrespiration

-0.753

TRC10-150 ug/mL Triclosanrespiration

0.849

TRZ10-25 ug/mL Thioridazinerespiration

3.713

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.290

menadione6-10 ug/mL Menadionerespiration

-0.849

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.453

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.760

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.161

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.247

NRP_1Non-replicating persistence stage 1dosRassociated

-0.247

Amp0.2mg/mL AmpicillincellWall

-0.436

Cephalexin20-100 ug/mL CephalexincellWall

0.430

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.060

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.698

EMB10-20 ug/mL EthambutolcellWall

-0.522

Eta12-40 ug/mL EthionamidecellWall

-0.405

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.312

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.030

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.270

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.595

BZA0.12 mg/mL BenzamidearomaticAmides

-0.075

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.205

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.237

H2O24 mM hydrogen peroxideDNAdamaging

-0.348

Levo10 ug/mL LevofloxacinDNAdamaging

0.129

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.250

Novobiocin10 ug/mL NovobiocinDNAdamaging

-1.011

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.081

UVUV-irradiationDNAdamaging

-0.203

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.608

Antimycin12.5-50 ug/mL Antimycin A?

-0.328

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.623

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.454

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.051

PA8240.2-2 ug/mL PA-824?

-0.029

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.314

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.415

Verapamil50 uM Verapamil?

-0.019

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.338

methoxatin10-20 ug/mL Methoxatin?